| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
arylacetamide deacetylase | 0.631 | 0.615 | 2.9E-03 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
apoptosis associated transcript in bladder cancer | 0.890 | 0.115 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2015 | 2018 | |||||||||
|
ATP binding cassette subfamily B member 1 | 0.344 | 0.885 | 1.3E-05 |
|
disease | 0.100 | None | 1.000 | 14 | 0 | 1994 | 2019 | ||||||||
|
ATP binding cassette subfamily B member 10 | 0.716 | 0.423 | 2.9E-08 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2020 | 2020 | ||||||||
|
ATP binding cassette subfamily B member 6 (Langereis blood group) | 0.431 | 0.885 | 8.6E-19 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
ATP binding cassette subfamily C member 1 | 0.445 | 0.808 | 1.2E-03 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 1996 | 2019 | ||||||||
|
ATP binding cassette subfamily C member 2 | 0.483 | 0.808 | 5.2E-47 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2002 | 2002 | ||||||||
|
ATP binding cassette subfamily C member 3 | 0.517 | 0.769 | 1.2E-26 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 1995 | 2018 | ||||||||
|
ATP binding cassette subfamily G member 2 (Junior blood group) | 0.419 | 0.885 | 2.1E-32 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2017 | 2018 | ||||||||
|
ABHD11 antisense RNA 1 (tail to tail) | 0.722 | 0.192 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | |||||||||
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | 0.427 | 0.885 |
|
disease | 0.050 | None | 0.800 | 5 | 0 | 1995 | 2018 | |||||||||
|
acetylcholinesterase (Cartwright blood group) | 0.445 | 0.885 | 1.00 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2018 | 2019 | ||||||||
|
atypical chemokine receptor 3 | 0.428 | 0.885 | 0.39 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2012 | 2018 | ||||||||
|
acid phosphatase 3 | 0.525 | 0.731 | 2.5E-16 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
acrosin | 0.493 | 0.846 | 1.2E-02 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
acyl-CoA synthetase short chain family member 1 | 0.743 | 0.346 | 3.1E-07 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
acyl-CoA synthetase short chain family member 2 | 0.506 | 0.808 | 1.1E-13 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2018 | 2019 | ||||||||
|
actin alpha 2, smooth muscle | 0.508 | 0.846 | 0.93 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
actin beta | 0.325 | 0.923 | 0.99 |
|
disease | 0.100 | None | 0.900 | 10 | 0 | 1991 | 2019 | ||||||||
|
actinin alpha 1 | 0.695 | 0.577 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
actinin alpha 4 | 0.508 | 0.808 | 1.00 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2010 | 2013 | ||||||||
|
activin A receptor type 1B | 0.663 | 0.385 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
ADAM metallopeptidase domain 10 | 0.489 | 0.846 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
ADAM metallopeptidase domain 15 | 0.626 | 0.577 | 2.4E-16 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
ADAM metallopeptidase with thrombospondin type 1 motif 1 | 0.555 | 0.654 | 0.72 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 |